ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 126

$1.69M Total Retail Price of All Prescriptions

Rank: 1 out of 126

690 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

32% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 19,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $105 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,163 626 S3 1 9
FUROSEMIDE 1,107 778 2 2
AMLODIPINE BESYLATE 835 578 3 1
LISINOPRIL 699 479 4 3
METOPROLOL TARTRATE 629 449 5 12
SIMVASTATIN 565 404 6 13
GABAPENTIN 532 374 7 25
METOPROLOL SUCCINATE 532 410 7 18
OMEPRAZOLE 530 376 9 26
POTASSIUM CHLORIDE 515 377 10 27
NEXIUM 499 313 11 23
METFORMIN HCL 485 348 12 36
PRAVASTATIN SODIUM 483 401 13 32
LEVOTHYROXINE SODIUM 440 372 14 16
ALLOPURINOL 399 313 15 10
CLOPIDOGREL 380 303 16 45
ATORVASTATIN CALCIUM 346 240 17 24
WARFARIN SODIUM 340 286 18 42
CARVEDILOL 320 177 19 8
CLONIDINE HCL 282 180 20 6
TRAMADOL HCL 281 245 21 28
RANITIDINE HCL 278 165 22 54
PANTOPRAZOLE SODIUM 266 180 23 36
GLIMEPIRIDE 248 131 24 52
CRESTOR 247 195 25 45
HYDROCHLOROTHIAZIDE 247 189 25 19
ZOLPIDEM TARTRATE 241 153 27 29
PLAVIX 240 195 28 59
TAMSULOSIN HCL 236 181 29 38
DONEPEZIL HCL 224 222 30 48
NAMENDA 206 206 31 51
ISOSORBIDE MONONITRATE ER 200 162 32 65
PROMETHAZINE HCL 192 55 R 33 76
TRAZODONE HCL 191 139 34 63
AZITHROMYCIN 183 110 35 71
AMOXICILLIN 177 115 36 98
LANTUS 171 86 37 50
QUETIAPINE FUMARATE 167 104 38 56
POLYETHYLENE GLYCOL 3350 160 116 39 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 96 40 66
SUCRALFATE 156 105 41 105
CYMBALTA 156 111 41 67
SERTRALINE HCL 154 114 43 53
ADVAIR DISKUS 149 109 44 83
ATENOLOL 147 104 45 41
DIOVAN 145 84 46 20
KLOR-CON M20 137 78 47 68
PAROXETINE HCL 128 109 48 122
RENVELA 128 69 48 4
SPIRONOLACTONE 125 73 50 33
LYRICA 125 70 50 123
SYNTHROID 122 113 52 70
MELOXICAM 117 98 53 72
CEPHALEXIN 116 70 54 99
FAMOTIDINE 116 105 54 73
ENALAPRIL MALEATE 114 90 56 89
GLIPIZIDE 114 86 56 80
LANTUS SOLOSTAR 112 76 58 93
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 70 59 64
HYDRALAZINE HCL 108 54 59 11
BENAZEPRIL HCL 107 71 61 40
CALCIUM ACETATE 107 44 61 17
CYCLOBENZAPRINE HCL 107 29 R 61 134
HUMALOG 106 59 64 135
LOSARTAN POTASSIUM 105 76 65 14
GLIPIZIDE ER 105 104 65 94
JANUVIA 104 60 67 47
SPIRIVA 102 68 68 107
FELODIPINE ER 102 75 68 139
SENSIPAR 102 72 68 7
AMITRIPTYLINE HCL 101 79 R 71 140
PREDNISONE 100 52 72 30
RISPERIDONE 100 68 72 102
PEN NEEDLE 97 51 74 108
KLOR-CON 10 95 82 75 144
KLOR-CON M10 95 74 75 108
ALENDRONATE SODIUM 91 74 77 58
METHOCARBAMOL 90 39 R 78 149
DOXYCYCLINE HYCLATE 90 68 78 78
SYMBICORT 89 50 80 150
ESCITALOPRAM OXALATE 87 75 81 55
FLUTICASONE PROPIONATE 87 45 81 96
VENLAFAXINE HCL ER 87 47 81 112
LIPITOR 83 65 84 75
NIFEDIPINE ER 81 55 85 15
PROAIR HFA 80 38 86 84
ROPINIROLE HCL 80 47 86 154
DIGOXIN 79 64 88 73
DIOVAN HCT 78 59 89 79
DIVALPROEX SODIUM 77 49 90 113
GLIPIZIDE XL 74 61 91 124
SINGULAIR 74 60 91 158
MECLIZINE HCL 72 62 93 119
TRIAMTERENE-HCTZ 72 40 93 96
COLCRYS 71 53 95 90
PROPRANOLOL HCL 69 60 96 117
CLOTRIMAZOLE-BETAMETHASONE 69 44 96 162
GLYBURIDE-METFORMIN HCL 69 56 R 96 162
METOCLOPRAMIDE HCL 68 31 99 164
FENOFIBRATE 68 42 99 126
GLYBURIDE 67 35 R 101 87
CILOSTAZOL 67 53 101 166
BYSTOLIC 64 55 103 43
CALCITRIOL 64 54 103 5
TRICOR 64 38 103 115
DILTIAZEM ER 63 52 106 127
MEGESTROL ACETATE 63 58 R 106 124
INSULIN SYRINGE 61 22 108 92
ISOSORBIDE DINITRATE 61 51 108 176
RAMIPRIL 61 52 108 31
NATEGLINIDE 60 32 111 180
VESICARE 60 49 111 180
GEMFIBROZIL 60 33 111 180
AMOX TR-POTASSIUM CLAVULANATE 59 30 114 105
NITROGLYCERIN PATCH 59 41 114 185
AMIODARONE HCL 58 56 116 131
NAPROXEN 57 32 117 187
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 117 60
AMLODIPINE BESYLATE-BENAZEPRIL 57 39 117 61
PHENYTOIN SODIUM EXTENDED 57 0 117 187
DIVALPROEX SODIUM ER 57 34 117 132
CIPROFLOXACIN HCL 56 41 122 49
MIRTAZAPINE 55 53 123 87
FLUCONAZOLE 55 36 123 191
AGGRENOX 55 45 123 191
COMBIVENT 55 36 123 135
FINASTERIDE 54 47 127 95
DOXAZOSIN MESYLATE 54 49 127 21
VERAPAMIL ER 54 53 127 132
ONGLYZA 54 41 127 113
BUMETANIDE 53 52 131 57
NOVOLOG 53 22 131 111
NITROSTAT 52 37 133 199
MONTELUKAST SODIUM 51 40 134 202
CITALOPRAM HBR 50 38 135 90
MUPIROCIN 50 28 135 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.